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ABSTRACT
Background: Apples are rich in bioactive polyphenols and fiber.
Evidence suggests that consumption of apples or their bioactive
components is associated with beneficial effects on lipid metabolism
and other markers of cardiovascular disease (CVD). However,
adequately powered randomized controlled trials are necessary to
confirm these data and explore the mechanisms.
Objective:We aimed to determine the effects of apple consumption
on circulating lipids, vascular function, and other CVD risk markers.
Methods: The trial was a randomized, controlled, crossover,
intervention study. Healthy mildly hypercholesterolemic volunteers
(23 women, 17 men), with a mean ± SD BMI 25.3 ± 3.7
kg/m2 and age 51 ± 11 y, consumed 2 apples/d [Renetta Canada,
rich in proanthocyanidins (PAs)] or a sugar- and energy-matched
apple control beverage (CB) for 8 wk each, separated by a 4-
wk washout period. Fasted blood was collected before and after
each treatment. Serum lipids, glucose, insulin, bile acids, and
endothelial and inflammation biomarkers were measured, in addition
to microvascular reactivity, using laser Doppler imaging with
iontophoresis, and arterial stiffness, using pulse wave analysis.
Results: Whole apple (WA) consumption decreased serum total
(WA: 5.89 mmol/L; CB: 6.11 mmol/L; P = 0.006) and LDL
cholesterol (WA: 3.72 mmol/L; CB: 3.86 mmol/L; P = 0.031),
triacylglycerol (WA: 1.17 mmol/L; CB: 1.30 mmol/L; P = 0.021),
and intercellular cell adhesion molecule-1 (WA: 153.9 ng/mL; CB:
159.4 ng/mL; P= 0.028), and increased serum uric acid (WA: 341.4
μmol/L; CB: 330 μmol/L; P = 0.020) compared with the CB. The
response to endothelium-dependent microvascular vasodilation was
greater after the apples [WA: 853 perfusion units (PU), CB: 760 PU;
P= 0.037] than after the CB. Apples had no effect on blood pressure
or other CVD markers.
Conclusions: These data support beneficial hypocholesterolemic
and vascular effects of the daily consumption of PA-rich apples by
mildly hypercholesterolemic individuals. This trial was registered at
clinicaltrials.gov as NCT01988389. Am J Clin Nutr 2019;00:1–
12.
Keywords: apple, polyphenols, flavanols, proanthocyanidins, fiber,
lipid, cholesterol, vascular, bile acids, sex
Introduction
Regular consumption of plant foods, including fruits, has been
consistently associatedwith a lower risk of cardiovascular disease
(CVD) (1). Apples represent 12.5% of all consumed fruits in
the world (2), due to their taste and convenience, and possibly
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also because of their purported health benefits. Epidemiological
studies suggest that a frequent apple intake is inversely associated
with acute coronary syndrome, total CVDmortality, and all-cause
mortality (3, 4).
Apples are an excellent source of polyphenols (typically
110 mg/100 g) and fiber (typically 2–3 g/100 g) and these
bioactive components may be responsible for the potential
health effects (5). Apple polyphenols include flavanols [catechin
and proanthocyanidins (PAs)] as the major class (71–90%),
followed by hydroxycinnamates (4–18%), flavonols (1–11%),
dihydrochalcones (2–6%), and anthocyanins (1–3%) which are
found only in red apples (5). PAs and flavanol monomers, as
extracts or within a food, have been shown to lower serum
cholesterol, raise HDL cholesterol, inhibit LDL oxidation,
activate endothelial nitric oxide synthase, prevent platelet ag-
gregation, and block inflammatory responses in atherosclerosis,
although data from human intervention studies are limited and
sometimes contradictory (6–8). In addition, pectin, the main
soluble fiber found in apples, is reported to affect transit time,
gastric emptying, and nutrient absorption, affecting lipid and
glucose metabolism (5). Pectin also appears to modulate the
gut microbiota, a key determinant of bile acid (BA) chemical
structure and thus signaling potential (5).
There is consistent evidence that apple consumption is
associated with hypolipidemic effects, with reductions in total
cholesterol (TC) and LDL cholesterol in animal models, but
these studies cannot be directly extrapolated to humans (5).
Human intervention studies also suggest potential lipid-lowering
effects of apples but results lack consistency, perhaps due to
differences in the apple products tested, which have included
fresh whole apples (WAs) (9–16), dry apples (17, 18), apple
skin (19), apple pomace (15), cloudy (15, 20, 21) and clear
apple juice (11,15), and pure apple polyphenols (8, 22, 23); dose
and molecular characteristics of the active components; study
duration; sample size; and the use of appropriate controls (5).
The effects of apples on endothelial function have been observed
in postprandial human studies (19, 24) but are inconsistent in
longer-term interventions (4-wk treatment) (17, 19), whereas
effects on systemic inflammation are limited (5).
In this 8-wk dietary intervention study, we examined the
hypothesis that the supplementation of the habitual diet of 40
healthy mildly hypercholesterolemic subjects with 2 fresh WAs
(Renetta Canada) daily for 8 wk would result in TC reduction
and beneficial effects on vascular function and other markers of
CVD, compared with a sugar-matched apple control beverage
(CB). Renetta Canada is an apple variety rich in PAs and
dihydrochalcones andwas previously shown to possess beneficial
effects on gut microbiota composition and activity in vitro (25).
Methods
Research ethics
The study (NCT01988389) was given a favorable ethical
opinion for conduct by the University of Reading Research
Ethics Committee [UREC Project No. 13/22 (AVAG/effect of
Apples on cardioVascular risk And Gut health study)]. The study
was conducted according to the guidelines laid down in the
Declaration of Helsinki of 1975 as revised in 1983. Subjects
provided written informed consent before participating and a
small remuneration was given for participation in the trial.
Participants
Forty-three generally healthy volunteers (18 men, 25 women),
aged 29–69 y, with BMI (in kg/m2) 19–33 and TC > 5.2
mmol/L (mildly hypercholesterolemic), were recruited from the
general population of Reading, Berkshire, United Kingdom
using human volunteer databases, posters, and adverts on
social media (Figure 1). Subjects first completed a health and
lifestyle questionnaire and then attended the Hugh Sinclair
Unit of Human Nutrition at the University of Reading in a
fasted state. After giving informed written consent, screening
measurements were performed, such as height, weight, blood
pressure, and blood measurements including lipid profile, liver
and kidney function markers, and full blood count, 2–4 wk
before commencing the trial. Subjects with an abnormal blood
biochemistry profile, based on standard clinical cutoffs, were
excluded. Further exclusion criteria included medical history of
heart disease (or family history) and diabetes mellitus; kidney,
liver, or pancreatic diseases; hematological and gastrointestinal
disorders; and medication for hyperlipidemia, hypertension,
hypercoagulation, inflammation, and gastrointestinal motility.
Other exclusion criteria were pregnancy (current or planned) or
lactation, smoking, history of alcohol misuse, antibiotic intake
<3 mo before the study, food supplement use (including fish
oil, vitamins, phytochemicals, probiotics, and prebiotics unless
willing to stop 2 mo before study commencement), habitual
intake of >1 apple/d, vegetarian and vegan diet, and planned
weight loss regime.
The primary outcome was changes in serum cholesterol. All
other outcomes were secondary and included the evaluation of
endothelial function, measured by laser Doppler imaging (LDI),
changes in blood pressure and arterial stiffness, measured with
the use of an ambulatory blood pressure monitor and pulse wave
analysis (PWA), respectively, and changes in serum lipids, BAs,
markers of inflammation, endothelial function, glycemic control,
and insulin resistance.
Study design
The present trial was a randomized, controlled, crossover,
dietary intervention study performed between November 2013
and August 2014. Forty-three volunteers were recruited onto the
study; 3 volunteers dropped out due to personal reasons and 40
subjects (17 men, 23 women) completed the trial (Figure 1). For
a 2-wk run-in period before the dietary intervention, volunteers
followed their habitual diet but were required not to consume
probiotics (e.g., live yogurts, fermented milk drinks), prebiotics
(e.g., inulin, fructooligosaccharide), and any apples, apple juice,
or apple-containing foods. Probiotics, prebiotics, and any other
apple products (apart from the provided items) were also strictly
avoided throughout the study period (20 wk). Volunteers were
randomly allocated into 2 groups, using a minimization program
(minim) (26), stratified by age [23–45 y (n = 13), 46–69 y
(n = 27)], sex (17 men, 23 women), BMI [<25 (n = 20), >25
(n = 20)], and TC [5.2–6.2 mmol/L (n = 26), >6.2 mmol/L
(n = 14)], to receive daily either 2 WAs or a sugar-matched CB
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FIGURE 1 Participant flow diagram of the AVAG (effect of Apples on cardioVascular risk And Gut health) study.
(Table 1, Figure 2). One group [n = 22 (10 men, 12 women);
mean± SD age: 51± 11 y; BMI: 25± 3; TC: 5.9± 0.7 mmol/L]
consumed 2 apples/d (340 g without core) for 8 wk, and then after
a 4-wk washout period, consumed 500 mL of a sugar-matched
apple CB (100 mL concentrate + 400 mL water) daily for a
further 8wk, whereas the other group [n= 18 (7men, 11women);
age: 52± 11 y; BMI: 26± 4; TC: 6.0± 0.6 mmol/L] received the
intervention foods in the reverse order (Figure 2). Volunteers were
asked to incorporate the intervention products into their normal
habitual diet, and understood that both products had potential
benefit. Clear instructions were given to eat the apple skin and
flesh and not to consume the apple core.
The study included 4 main visits before and after each inter-
vention period (weeks 1, 8, 12, and 20) (Figure 2). Twenty-four
hours before each study visit, volunteers were asked to collect
their urine and refrain from intensive exercise, alcohol, oily fish,
and caffeine intake (e.g., coffee, tea). The night before they
consumed a standardized low-fat, low-flavonoid meal followed
by an overnight fast consuming only water. The volunteers were
asked to attend the Hugh Sinclair Unit of Human Nutrition in
the morning of each of the 4 study visit days in a fasted state.
During these visits, several measurements were taken, including
anthropometrics (height, weight, waist circumference), body fat
composition (body composition analyzer, Tanita BC-418 digital
scale), blood pressure (30-min measurement), arterial stiffness
(PWA), and microvascular reactivity (LDI with iontophoresis).
Moreover, volunteers returned their 24-h urine collection and
a fasted blood sample was collected before they were offered
breakfast. Volunteers received the intervention products on the
visit day, and then every fortnight when they were also asked if
there had been any changes to their lifestyle, such as diet, exercise
levels, andmedication. Finally, compliance was assessed with the
daily completion of a tick sheet.
Intervention products
Fresh apples from the same harvest (green variety “Renetta
Canada”) grown in Val di Non, Trentino, Italy were used as the
intervention food. All apples were kindly provided by Melinda
SCA, Cles, Trentino. A total of 7337 apples were delivered to
the University of Reading, United Kingdom in 7 batches between
November 2013 andMay 2014. There was no difference in the PA
concentration of the apples during storage and between the differ-
ent batches throughout the study (Supplemental Figure 1). After
collection, the apples were stored in the dark at 4◦C for≤4–6 wk.
The CB was a commercially available apple juice squash consist-
ing of 50% apple juice from concentrate and added sugar which
matched the total sugar content of the apples. The daily dietary
content of the intervention products is shown in Table 1. The ap-
ples’ nutritional composition was analyzed by Campden BRI lab-
oratories, United Kingdom and the detailed polyphenol content
was measured in the laboratory of Fondazione EdmundMach ac-
cording to themethods of Gris et al. (28) andVrhovsek et al. (27).
Diet diary analysis
Participants were asked to complete a detailed 4-d diary of
all foods and drinks consumed (3 weekdays and 1 day at the
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TABLE 1 Nutritional composition of the intervention products (daily
portion)1
Component Whole apples2 Control beverage3
Energy,4 kJ 925 699
Energy,4 kcal 221 167
Fat,4 g 0.7 <0.1
Protein,4 g 1 <0.1
Carbohydrate total,4 g 58 42
Carbohydrate available,4 g 49 42
Total sugar,4 g 44 41
Glucose,4 g 8 18
Fructose,4 g 23 20
Sucrose,4 g 12 3
Total dietary fiber4 (AOAC), g 8.5 <0.5
Soluble fiber4 (AOAC), g 3.7 <0.5
Insoluble fiber4 (AOAC), g 4.8 <0.5
Vitamin C,4 mg 21 <3
Chlorogenic acid,5 mg 83 ± 8.9 0.9 ± 2.1
Cryptochlorogenic acid,5 mg 0.8 ± 0.4 0.1 ± 0.6
Ellagic acid,5 mg 0.2 ± 0.1 0 ± 0
Phloridzin,5 mg 13.8 ± 3.5 0.3 ± 0.6
Quercetin-3-O-arabinoside,5 mg 2.3 ± 1.0 0.03 ± 0.2
Quercetin-3-O-glucoside,5 mg 2.3 ± 1.9 0.03 ± 0.2
Quercetin-Glc-Rha (rutin),5 mg 1.2 ± 1.5 0.03 ± 0.2
Catechin,5 mg 5.3 ± 2.3 0.01 ± 0.03
Epicatechin,5 mg 27 ± 6.5 0.02 ± 0.09
Procyanidin B1,5 mg 23 ± 5.6 0.01 ± 0.03
Procyanidin B2,5 mg 176 ± 26 0.06 ± 0.32
Oligomeric PAs (DP > 2)6 854 ± 233 1 ± 1.7
Mean DP6 7.1 3.5
Sum of polyphenols7 990 ± 259 2.5 ± 5.7
1Values are means ± SDs for polyphenols.
2Consists of a 340-g daily serving (2 apples; Renetta Canada) without
the core including skin.
3Consists of a 100-mL control beverage + 400-mL water daily serving
(sugar-matched control).
4Measured by Campden BRI laboratories, UK, mixture of 3 apples.
5Quantified in house according to Vrhovsek et al. (27), measurement of
15 apples from December to April.
6Quantified in house according to Gris et al. (28), measurement of 15
apples from December to April. DP, degree of polymerization; PA,
proanthocyanidin.
7Sum of all individual polyphenols and oligomeric PAs (DP > 2).
weekend), the week before each of the 4 main visits. The
food diaries were analyzed using Dietplan6 (Forestfield Software
Ltd.) to determine the macro- and micronutrient content of the
participants’ diet based on UK food databases (29). Flavonoid
intake was assessed by using the USDA Flavonoid Database and
by an “in-house” compositional analysis of fruits and vegetables
as described by Chong et al. (30).
Anthropometric, body fat composition, and blood pressure
analysis
Height, weight, waist circumference, body fat percentage, and
blood pressure were measured on 4 occasions, at the beginning
and the end of the 2 intervention periods. Body fat composition
(percentage) was measured with a Tanita body composition
monitor (Tanita BC-418 digital scale, Tanita Europe) based
on bioelectrical impedance technology. Measurements were
performed under normal settings with participants wearing light
clothing. Blood pressure was recorded using an ambulatory blood
pressuremonitor whichwas adjusted to take ameasurement every
5 min. Participants were relaxed, seated in a quiet, light room for
15 min before the commencement of the measurement, which
lasted for 30 min and included 6 measurements.
Assessment of vascular function
All measurements were performed in a quiet temperature-
controlled room (mean ± range: 22 ± 1◦C), with participants
in a supine position after a 30-min rest. Microvascular reactivity
was measured using a moorLDI2 laser Doppler Imager with
iontophoresis (Moor Instruments Ltd.) as previously described
(31). Briefly, acetylcholine chloride (2.5 mL, 1% in 0.5%
NaCl solution) for the measurement of endothelium-dependent
reactivity and sodium nitroprusside (2.5 mL, 1% in 0.5%
NaCl solution) for the measurement of endothelium-independent
reactivity were delivered transdermally on the forearm via
iontophoresis using ION6 chambers (Moor Instruments). Current
delivery was controlled and repeated scans were taken, giving
a total charge of 8 millicoulombs. Microvascular response
was calculated by using the area under the flux-versus-time
curve (AUC), measured as perfusion units (arbitrary). PWA was
measured using a high-fidelity applanation tonometer to detect
and capture electronically the shape of the radial arterial pulse
(SphygmoCor system,AtCorMedical). The radial artery pressure
waveform was then calibrated with the brachial systolic and
diastolic pressure measurements (performed in the traditional
manner at the brachial artery with an inflated cuff). The
SphygmoCor system then converted this peripheral waveform to
a central aortic pressure waveform using general transfer function
FIGURE 2 Study design of a randomized, controlled, crossover study in which 40 healthy volunteers (Group 1: n = 22; Group 2: n = 18) received daily
2 WAs (340 g without core) or a CB (100 mL concentrated + 400 mL water) for a period of 8 wk each, separated by a 4-wk washout period. Fasted blood and
a 24-h urine sample were collected on each study visit (weeks 1, 8, 12, and 20), and ambulatory blood pressure, vascular reactivity, and arterial stiffness were
assessed. CB, control beverage; WA, whole apple.
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algorithms (32). Moreover, several indexes were quantified from
the peripheral and central waveforms: central systolic pressure,
central diastolic pressure, central pulse pressure, central mean
pressure, heart rate (HR), and central augmentation pressure-to-
pulse height ratio (C-AGPH)—also known as the Augmentation
Index (AIx) or arterial stiffness. Given that the AIx depends on
HR, it was corrected for an HR of 75 beats per minute (C-AGPH-
HR75). Measurements were performed in triplicate by a single
trained operator.
Blood and urine sample collection
For each volunteer, blood samples were collected into separate
vacutainer tubes (Greiner Bio-One Ltd.), containing EDTA or
lithium heparin (LH) anticoagulants for plasma and a clot
activator for serum [serum separator tubes (SSTs)]. After
collection, the EDTA and LH tubes were immediately put on
ice for transportation to the laboratory. Cells were then removed
from plasma by centrifugation at 1800 × g for 15 min at 4◦C.
Aliquots (0.5 mL) of the supernatant (plasma) were immediately
transferred into clean cryogenic (polypropylene) vials and stored
at −80◦C. To obtain serum, SSTs were left undisturbed at room
temperature for 30 min after collection. The supernatant (serum)
was then obtained by centrifugation at 1800 × g for 15 min
at 21◦C and aliquots were put into separate cryogenic vials for
storage at −20◦C.
For the collection of the urine, volunteers were provided with
a urine pot containing 10 mL 1 M hydrochloric acid, ice packs,
and an isothermic bag and they were instructed to start collecting
the sample the morning before the study visit and for 24 h.
Once the urine was received in the lab, its pH was reduced to
4 with the further addition of 1 M hydrochloric acid, then it was
centrifuged at 1800 × g for 10 min at 4◦C, divided into aliquots,
and stored at−80◦C until further analysis. Urine volumewas also
recorded. Analysis of blood and urine was performed when the
intervention study was completed. All samples from each subject
were analyzed together to reduce interbatch variation.
Biochemical analysis
Concentrations of serum lipids [total cholesterol (TC), HDL
cholesterol, triacylglycerol (TAG), and nonesterified fatty acids
(NEFAs)], glucose, albumin, and uric acid were measured using
an Automatic Analyzer ILAB 600 with appropriate enzyme-
based kits (Instrumentation Laboratory Ltd.) and quality controls
(Alpha Laboratories Ltd.). Controls were run with each batch and
their values were within the range specified by the manufacturers.
LDL cholesterol was estimated by using the Friedewald formula
(LDL cholesterol = TC – HDL cholesterol − TAG/2.19).
ELISA kits were used for the determination of serum insulin
(Dako Ltd.), adiponectin, and endothelin (R&D Systems Europe
Ltd.) according to the manufacturer’s instructions. An Adhesion
Molecule Luminex Performance Assay 4-plex kit was used
for the determination of E-selectin, P-selectin, vascular cell
adhesion molecule-1 (VCAM-1), and intercellular cell adhesion
molecule-1 (ICAM-1) (R&D Systems Europe Ltd.) using a flow
cytometry–based Luminex 200TM System (Invitrogen, Thermo
Fisher Scientific). A Milliplex MAP human cytokine kit (Merck-
Millipore) was used for the determination of TNF-α, IL-1β, and
IL-6 according to the manufacturer’s instructions. IL-1β and IL-6
were under the detection limit and are not reported here.
BAs in blood
BAs were quantified by the isotopic dilution method described
elsewhere (33) and modified for the purpose of the current
sample set. Briefly, 100 μL plasma was placed in Sirocco 96-
well plates followed by 200 μL internal standards in methanol
and 200 μL methanol:water (90:10, vol:vol) with 0.1% formic
acid. Samples were filtered and the residue was extracted with
400 μL acetonitrile:acetone (80:20, vol:vol) with 0.1% formic
acid. The extract was evaporated until dryness and resolved
with 200 μL methanol:water (50:50, vol:vol) before injection.
Samples were analyzed using a UHPLC (ultra-HPLC) UltiMate
3000 (Dionex) coupled with a Triple Quad 5500 (AB Sciex) mass
spectrometer. Data were acquired according to multiple reaction
monitoring methodology and results were expressed using an
appropriate internal standard. Raw data were processed by AB
Sciex Analyst 1.6.1 software. A detailed method description
and validation can be found in the Supplemental Methods.
The ursodeoxycholic acid was excluded from the statistical
analysis because >30% of measures were missing. Missing
values of glycolithocholic acid (20measures, distributed among 8
subjects) and glycoursodeoxycholic acid (GUDCA) (4 measures,
distributed among 2 subjects) were imputed with a random
number ranging between 0 and the limit of quantification for each
compound (Supplemental Methods, Supplemental Tables 1–3).
Phloretin metabolites in urine
Urine samples were submitted to untargeted chemical analysis
for the identification of phloretin metabolites as biomarkers
of apple consumption (Supplemental Methods) (34). Phloretin
glucuronide was not detected in 16% of measures and phloretin
glucuronide sulfate in 61% of measures; these were detected
almost solely in the presence of apple intake. Missing values
were imputed with a random number ranging between 0 and
5,000, which is compatible with the electrical noise of the mass
spectrometer.
Statistics
The primary outcome of the study was to measure relative
changes in serum TC and it was calculated that 38 volunteers
were required to detect a 5% change (P < 0.05 and 90% power),
assuming a 6-mmol/L mean TC with a 0.41-mmol/L within-
subject SD. On the basis of this power calculation, 43 volunteers
were recruited to allow for a 10% dropout rate. Samples from
each participant were recoded to protect volunteer identity and to
mask treatment groups during the analysis.
Exploratory analysis on the study primary outcome (TC)
was initially performed by calculating, for each individual, the
difference (C) in TC after the consumption of WAs and CB.
Intervention-specific baselines were also taken into account [C
= (Capple − Capple baseline) − (Ccontrol − Ccontrol baseline)]. The
presence of a significant difference in the TC concentration was
then tested by a 1-sample t test against a null hypothesis of
C = 0. The dependence of C on the main study factors (age,
BMI, and sex) was also assessed in this phase (Supplemental
Figures 2–4).
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Differences between the dietary components of apples and the
CB were assessed using a t test, whereas the PA content of apples
throughout storagewas assessed using anANOVA test using IBM
SPSS version 21 (SPSS Inc.).
In order to test the difference in treatment response means,
baseline and postbaseline data were jointly modeled applying
mixed-effect linear modeling, accounting for subject variability
(35). The model assumes that the effects of systematic bias
typical of crossover studies, such as carryover, are negligible. As
suggested for the 2-period 2-treatment design (35), a formal test
on carryover was not performed. Restricted maximum likelihood
was used to estimate the model parameters. To perform model
optimization, the distribution of the conditional residuals of the
models was inspected to assess normality and homoscedasticity,
and exclude the presence of groups. To improve the distribution
of skewed variables and the conditional residuals of the model,
log10 transformation was applied. For these variables, the model
estimates for both baselines and treatments are presented as back-
transformed values, which correspond to the median measured
concentrations, in order to facilitate the interpretation of the
results and allow their direct comparison with published clinical
ranges. The uncertainty on the inference estimates was calculated
with a bootstrap operation (500 repeats) and is indicated as
(possibly back-transformed) 95% CIs.
In order to provide all the information to properly interpret the
study findings, the treatment effect (computed as the difference
between the value of a variable after WA intake and after CB
consumption), as well as the estimated sequence and period
effect, and the number of observations and subjects used for
building each model are also explicitly reported (Supplemental
Tables 4–7) (36). These results were not back-transformed from
the logarithmic scale in order to improve interpretation. It is
worth noting that with our modeling strategy the significance of
the treatment effect can also be reliably assessed in the presence
of period/sequence effects, even if the estimation of the effect is
suboptimal (37).
The mixed linear models were built in R (www.r-project.org)
version 3.5.0 by using packages lme4 version 1.1-17 (38) and
lmerTest version 3.0-1 (39), whereas the CIs were computed
using the package stats. P values were computed using the
Kenward-Roger approximation and 0.05 was chosen as the
significance threshold.
The association between TC and BAs in women was tested
without taking into account baselines. The predictors were cho-
sen from among the BAs, which were log transformed, centered,
and scaled using the R package LaplacesDemon version 16.1.0.
The study design factors (age, treatment, sequence, period) were
also included in the model and age was centered and scaled in
the same way as the BAs. Both R2 and2 indicate that the model
fit is good, being 0.961 and 0.960, respectively. The use of a
mixed linear model also allowed us to take into account subject
variability together with the grouping of the samples within the 2
sequences of the crossover design. In particular, subject nesting
within the sequence was defined as a random effect.
Results
Nutritional composition analysis of intervention products
Table 1 presents the detailed nutritional composition analysis
of the intervention products. Apples contained higher amounts
of polyphenols and fiber than the CB (P < 0.05). In particular,
a daily dose of 340 g apples provided 990 mg polyphenols
(presented as the sum of the individual phenolic compounds), 854
mg PAs, and 8.5 g total fiber (3.7 g soluble) compared with 2.5
mg polyphenols, 1 mg PAs, and <0.5 g total fiber from the daily
intake of 500 mL sugar-matched CB (Table 1).
Study population characteristics, dietary intakes, and
compliance
Of the 43 volunteers who started the study, 40 completed
all visits (23 women, 17 men). Three participants dropped out
for personal reasons. No adverse effects were reported during
the study. The volunteers’ age range was 29–69 y (mean: 51
y) and BMI was between 18.4 and 33.4 kg/m2 (mean: 25.3).
Volunteers had mean TC above that considered physiologically
normal (6.08 mmol/L compared with guideline values of <5.2
mmol/L). Table 2 and Supplemental Table 4 show the baseline
measurements before the 2 treatments. There was no effect of
the intervention on body weight, BMI, waist circumference,
and body fat percentage throughout the 20-wk period (Table 2,
Supplemental Table 4). There was no change in daily energy
and dietary carbohydrates, sugars, fat, and protein (Table 3,
Supplemental Table 5). During theWA intervention, daily dietary
fiber (P = 0.001) and flavonoid intake (P = 0.001) increased
compared with the CB, suggesting that the participants complied
with the dietary protocol (Table 3, Supplemental Table 5).
Compliance was further confirmed by the higher concentrations
of urinary biomarkers of apple intake in the WA group compared
with the CB group (P < 0.05). Figure 3 shows the log10 value
of intensities for urinary phloretin glucuronide (Figure 3A) and
phloretin glucuronide sulfate (Figure 3B) measured in urine
samples throughout the intervention. Phloretin glucuronide and
phloretin glucuronide sulfate were detected almost exclusively
after WA intake.
Biochemical analysis
Table 2 and Supplemental Table 4 show the blood biochemical
parameters. WA decreased serum TC (P = 0.006), LDL
cholesterol (P = 0.031), and TAG (P = 0.021) compared with
the CB. The WA intervention increased uric acid (P = 0.020)
compared with the CB. There were no differences in the
concentrations of circulating HDL cholesterol, NEFAs, glu-
cose, insulin, TNF-α, albumin, adiponectin, and endothelin
(Table 2, Supplemental Table 4). There was no effect of
treatment on plasma BA concentrations (Table 4, Supplemental
Table 6).
Vascular function, blood pressure, arterial stiffness and
endothelial function markers
The response to endothelium-dependentmicrovascular vasodi-
lation (acetylcholine) was greater after the WA intake compared
with the CB (P = 0.037). There was no effect on blood
pressure or other indexes calculated from peripheral and central
pulse waveforms (PWA) (Table 5, Supplemental Table 7). WA
consumption reduced plasma ICAM-1 (P = 0.028) compared
with the CB (Table 2, Supplemental Table 4). No differences
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TABLE 2 Anthropometric characteristics and blood biochemistry in mildly hypercholesterolemic participants BT (week 1) and AT (week 8) with WAs or
CB1
WAs CB
Parameters L n/N BT (95% CI) AT (95% CI) BT (95% CI) AT (95% CI) P value
Anthropometrics
Weight, kg 160/40 72.1 (67.66, 76.58) 72.3 (67.86, 76.78) 72.2 (67.74, 76.66) 72.4 (67.96, 76.88) 0.677
BMI, kg/m2 160/40 25.3 (24.15, 26.51) 25.4 (24.22, 26.57) 25.3 (24.17, 26.53) 25.4 (24.27, 26.63) 0.500
Waist, cm 144/39 88.5 (85.01, 92.05) 88.5 (85.01, 92.05) 89.0 (85.51, 92.53) 88.5 (84.98, 92.00) 0.895
Fat, % 152/40 28.8 (26.49, 31.18) 29.2 (26.87, 31.55) 29.0 (26.68, 31.36) 29.0 (26.67, 31.35) 0.484
Trunk fat, % 150/40 28.1 (26.01, 30.16) 28.6 (26.51, 30.67) 28.2 (26.09, 30.24) 28.2 (26.12, 30.27) 0.300
Blood biochemistry
Total cholesterol, mmol/L 152/38 6.08 (5.84, 6.33) 5.89 (5.64, 6.14) 6.05 (5.80, 6.30) 6.11 (5.86, 6.36) 0.006
LDL cholesterol, mmol/L 152/38 3.89 (3.67, 4.11) 3.72 (3.50, 3.95) 3.83 (3.61, 4.05) 3.86 (3.64, 4.08) 0.031
HDL cholesterol, mmol/L 152/38 1.62 (1.49, 1.75) 1.58 (1.46, 1.71) 1.62 (1.50, 1.75) 1.61 (1.48, 1.74) 0.246
TAG, mmol/L  152/38 1.17 (1.04, 1.32) 1.17 (1.04, 1.32) 1.19 (1.06, 1.35) 1.30 (1.15, 1.46) 0.021
NEFAs, μmol/L  152/38 456.9 (402.23, 518.98) 431.3 (379.74, 489.97) 456.3 (401.72, 518.32) 426.1 (375.09, 483.96) 0.807
Glucose, mmol/L 152/38 5.03 (4.88, 5.17) 5.04 (4.89, 5.18) 5.14 (5.00, 5.29) 5.09 (4.95, 5.24) 0.229
Insulin, pmol/L  160/40 33.8 (28.80, 39.79) 34.3 (29.15, 40.27) 35.9 (30.51, 42.16) 38.7 (32.89, 45.45) 0.051
TNF-α, pg/mL 160/40 6.5 (5.69, 7.31) 6.1 (5.30, 6.92) 6.2 (5.44, 7.06) 6.5 (5.70, 7.33) 0.106
Albumin, g/L 152/38 44.1 (43.32, 44.94) 43.3 (42.51, 44.13) 44.2 (43.43, 45.06) 43.8 (42.95, 44.57) 0.177
Adiponectin, μg/mL  152/38 6.4 (5.10, 8.11) 6.6 (5.20, 8.26) 6.4 (5.04, 8.01) 6.2 (4.92, 7.81) 0.071
Endothelin, pg/mL  160/40 1.1 (1.04, 1.26) 1.2 (1.06, 1.27) 1.1 (1.02, 1.23) 1.1 (1.03, 1.24) 0.561
Uric acid, μmol/L 152/38 337.3 (313.65, 360.88) 341.4 (317.75, 364.98) 338.1 (314.46, 361.69) 330.0 (306.41, 353.64) 0.020
VCAM-1, ng/mL  152/38 696.6 (638.88, 759.55) 665.7 (610.56, 725.88) 682.6 (626.05, 744.30) 690.8 (633.60, 753.28) 0.090
ICAM-1, ng/mL  152/38 152.6 (133.04, 174.94) 153.9 (134.22, 176.48) 156.5 (136.44, 179.41) 159.4 (139.04, 182.83) 0.028
E-selectin, ng/mL  152/38 32.1 (28.82, 35.72) 32.8 (29.45, 36.50) 32.4 (29.11, 36.09) 33.3 (29.90, 37.07) 0.417
P-selectin, ng/mL  152/38 34.7 (32.16, 37.34) 34.7 (32.17, 37.35) 35.6 (33.06, 38.39) 35.2 (32.69, 37.95) 0.214
1Values are means (for nontransformed variables mean is equal to median) or medians (for the log-transformed variables) with (500) bootstrap 95% CIs
estimated with a joint mixed-effect linear model on BT and AT data, adjusted for subject variability. The treatment effect is statistically significant when
P < 0.05. AT, after treatment; BT, before treatment; CB, control beverage; ICAM-1, intercellular cell adhesion molecule-1; L, the model was built using the
log10-transformed variable and the values are back-transformed in the original scale for the reader’s convenience; n, number of observations; N, number of
subjects; NEFA, nonesterified fatty acid; TAG, triacylglycerol; VCAM-1, vascular cell adhesion molecule-1; WA, whole apple.
were observed for the other adhesion molecules (Table 2,
Supplemental Table 4).
Exploratory association between TC response and BA
changes
Our initial exploratory analysis showed that WA consumption
reduced TC compared with the CB, but also suggested that the
level of response to the intervention could be different for men
and women (Supplemental Figures 2–4). Although the study
was not designed to test this hypothesis, exploratory analysis was
performed which involved running our full statistical model for
TC (primary outcome) separately for the 2 sexes, in order to
provide new, even if not conclusive, evidence. TC was reduced
after WA intake only in women (treatment effect: −0.33; CI:
−0.53, −0.12; P = 0.002).
Furthermore, a univariate mixed linear model, taking into
consideration the volunteers’ age in addition to the study design,
TABLE 3 Dietary nutrient intake in mildly hypercholesterolemic participants BT (week 1) and AT (week 8) with WAs or CB1
WAs CB
Parameters T n/N BT (95% CI) AT (95% CI) BT (95% CI) AT (95% CI) P value
Energy, kJ L 156/39 7396 (6716, 8144) 8195 (7442, 9024) 7363 (6687, 8108) 8097 (7353, 8917) 0.680
Energy, kcal L 156/39 1769 (1606, 1949) 1947 (1768, 2145) 1749 (1588, 1927) 1926 (1749, 2122) 0.708
Carbohydrates, g 156/39 194 (174, 214) 241 (221, 261) 198 (178, 218) 229 (209, 249) 0.144
Total sugar, g 156/39 91.3 (79.8, 102.9) 119.6 (108.1, 131.2) 84.8 (73.3, 96.4) 122.2 (110.7, 133.8) 0.670
Fat, g L 156/39 67.8 (59.9, 76.7) 69.5 (61.4, 78.6) 66.2 (58.5, 74.9) 69.5 (61.5, 78.7) 0.983
Protein, g L 156/39 71.9 (65.8, 78.7) 75.4 (69.0, 82.5) 72.9 (66.6, 79.7) 74.1 (67.8, 81.0) 0.637
Fiber (AOAC), g 156/39 20.6 (18.3, 22.8) 26.9 (24.6, 29.2) 20.5 (18.2, 22.8) 20.3 (18.0, 22.5) 0.001
Total flavonoids, mg S 156/39 438 (298, 603) 1534 (1263, 1833) 517 (365, 696) 426 (289, 589) 0.001
1Values are means (for nontransformed variables mean is equal to median) or medians (for the log- or square root-transformed variables) with (500)
bootstrap 95% CIs estimated with a joint mixed-effect linear model on BT and AT data, adjusted for subject variability. The treatment effect is statistically
significant when P < 0.05. AT, after treatment; BT, before treatment; CB, control beverage; n, number of observations; N, number of subjects; T, the model
was built using a transformed version of the variable (L = log10, S = square root) and the values are back-transformed in the original scale for the reader’s
convenience; WA, whole apple.
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FIGURE 3 Measured values of urinary phloretin glucuronide (A) and phloretin glucuronide sulfate (B) for each visit, for both the treatments. Dots are
individual values. Vertical dotted lines intersecting the x axis represent each visit; sequence WA–CB is plotted to the left of the vertical dotted lines and
sequence CB–WA to the right of them. The boxplots represent the mean values and the 95% bootstrap CIs as computed by the mixed linear models of treatment
effect. Red: estimates corresponding to WA intake; blue: estimates corresponding to CB intake; gray: estimates corresponding to both baselines (initial and
intermediate). CB, control beverage; WA, whole apple.
confirmed the link between TC and circulating BAs [lithocholic
acid (LCA) and GUDCA] (Supplemental Table 8; coefficient
values represented in Supplemental Figure 5). In particular, the
model showed that WA intake produced, on average, a significant
decrease in TC and, given that the TC concentration increased
with age, the apple intake attenuated this effect. Moreover, the
increase in LCA was associated with an increase in TC and, after
WA consumption, TC decreased as GUDCA increased. Similar
results were obtained with other hydrophilic BAs including
glycocholic acid and taurocholic acid (data not shown).
Discussion
In the present randomized controlled trial, of 40 men and
women with moderately raised serum TC, consumption of 2
fresh WAs (Renetta Canada, 340 g) daily decreased serum
TC, LDL cholesterol, and plasma ICAM-1 with no detrimental
effect onHDL-cholesterol concentrations comparedwith a sugar-
matched control. Few human intervention studies have focused
specifically on fresh apples (11–16). Two early studies reported
that 2–3 apples/d decreased TC in moderately hypercholes-
terolemic participants from baseline, although there was no
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TABLE 4 Fasted circulating plasma bile acid concentrations in mildly hypercholesterolemic participants BT (week 1) and AT (week 8) with WAs or CB1
WAs CB
Parameters L n/N BT (95% CI) AT (95% CI) BT (95% CI) AT (95% CI) P value
Cholic acid, nM  160/40 55.4 (36.9, 83.2) 41.5 (27.6, 62.3) 38.7 (25.8, 58.2) 49.0 (32.6, 73.6) 0.346
Chenodeoxycholic acid, nM  160/40 44.4 (29.7, 66.3) 34.0 (22.8, 50.8) 35.2 (23.6, 52.5) 40.0 (26.8, 59.7) 0.344
Deoxycholic acid, nM  160/40 93.9 (67.4, 130.7) 98.5 (70.7, 137.1) 99.1 (71.2, 137.9) 105.4 (75.7, 146.7) 0.603
Lithocholic acid, nM  160/40 5.9 (5.0, 6.9) 6.1 (5.1, 7.1) 6.1 (5.2, 7.2) 6.4 (5.4, 7.5) 0.523
Glycocholic acid, nM  160/40 86.8 (64.3, 117.2) 62.9 (46.6, 84.8) 73.0 (54.1, 98.5) 62.5 (46.3, 84.3) 0.967
Glycochenodeoxycholic acid, nM  160/40 226.1 (164.5, 310.9) 191.1 (139.0, 262.7) 184.0 (133.9, 253.0) 188.6 (137.2, 259.2) 0.928
Glycodeoxycholic acid, nM  160/40 79.8 (54.0, 117.8) 76.9 (52.1, 113.6) 70.2 (47.6, 103.7) 66.0 (44.7, 97.5) 0.261
Glycolithocholic acid, nM  140/38 6.2 (4.7, 8.2) 5.1 (3.9, 6.7) 5.0 (3.8, 6.6) 4.9 (3.7, 6.4) 0.815
Glycoursodeoxycholic acid, nM  156/40 23.2 (15.4, 35.0) 20.2 (13.4, 30.5) 21.0 (13.9, 31.6) 21.7 (14.4, 32.6) 0.656
Taurocholic acid, nM  160/40 12.3 (9.0, 16.8) 9.4 (6.9, 12.8) 10.4 (7.6, 14.2) 9.3 (6.8, 12.7) 0.959
Taurochenodeoxycholic acid, nM  160/40 25.8 (18.6, 35.6) 22.1 (16.0, 30.5) 23.8 (17.2, 32.9) 22.6 (16.4, 31.3) 0.847
Taurodeoxycholic.acid, nM  160/40 13.8 (9.8, 19.4) 12.5 (8.9, 17.5) 12.2 (8.7, 17.2) 11.2 (8.0, 15.7) 0.424
Taurolithocholic acid, nM  160/40 2.3 (2.1, 2.7) 2.3 (2.0, 2.6) 2.2 (2.0, 2.5) 2.1 (1.8, 2.3) 0.235
1Values are means (for nontransformed variables mean is equal to median) or medians (for the log-transformed variables) with (500) bootstrap 95% CIs
estimated with a joint mixed-effect linear model on BT and AT data, adjusted for subject variability. AT, after treatment; BT, before treatment; CB, control
beverage; L, the model was built using the log10-transformed variable and the values are back-transformed in the original scale for the reader’s convenience;
n, number of observations; N, number of subjects; WA, whole apple.
control (9, 10). Later studies in normocholesterolemic (11),
hypercholesterolemic (12), and elderly subjects (13) showed
no effects, or reported adverse effects on blood lipids (14). A
borderline significant decrease in serum TC and LDL cholesterol
was found after consumption of fresh WAs (550 g/d) compared
with a control period (15). More recently, and in support of
our results, TC and LDL cholesterol decreased after the daily
consumption of 2 Annurca apples (200 g/d) (16). The potential
ability of apples to reduce serum TC has been attributed mainly
to the fiber fraction, pectin in particular; however, polyphenols
may also play an important role (5). Pure apple polyphenols at
daily doses between 600 (23) and 1500 mg (22) decreased TC
and LDL cholesterol. In contrast, a cloudy apple juice (803 mg
polyphenols) had no effects on blood lipids (20). A total of 990
mg polyphenols (854 mg oligomeric PAs) per day was provided
by 2 Renetta Canada apples in our study, which supports the
hypothesis that polyphenols play a role in cholesterol lowering.
Furthermore, 6 g pectin/d has been reported to lower blood
TABLE 5 Vascular function, blood pressure, and PWA indexes in mildly hypercholesterolemic participants BT (week 1) and AT (week 8) with WAs or CB1
WAs CB
Parameters L n/N BT (95% CI) AT (95% CI) BT (95% CI) AT (95% CI) P value
LDI
Ach AUC, PU  132/33 821 (742.5, 908.8) 853 (771.0, 943.6) 784 (708.6, 867.3) 760 (686.9, 840.7) 0.037
SNP AUC, PU  132/33 881 (790.5, 982.6) 911 (816.8, 1015.3) 853 (765.5, 951.5) 829 (743.1, 923.8) 0.135
ABPM
PP, mm Hg  160/40 42 (39.5, 44.6) 41 (38.5, 43.4) 42 (39.4, 44.4) 41 (38.9, 43.8) 0.699
Brachial SBP, mm Hg  160/40 121 (117.0, 125.0) 120 (116.4, 124.3) 121 (117.0, 125.0) 122 (117.7, 125.7) 0.167
Brachial DBP, mm Hg 160/40 79 (76.1, 81.3) 79 (76.7, 82.0) 79 (76.5, 81.7) 80 (77.6, 82.9) 0.367
PWA
Central SBP, mm Hg  148/37 114 (109.6, 119.6) 113 (108.7, 118.6) 115 (110.5, 120.5) 115 (109.8, 119.8) 0.388
Central DBP, mm Hg 148/37 76 (73.2, 78.7) 75 (72.2, 77.7) 76 (73.2, 78.7) 75 (72.6, 78.0) 0.700
Central PP, mm Hg  148/37 38 (35.1, 41.5) 38 (35.1, 41.6) 39 (36.1, 42.7) 39 (36.2, 42.8) 0.168
Central MP, mm Hg 148/37 93 (89.7, 96.6) 92 (88.6, 95.5) 94 (90.1, 97.1) 93 (89.4, 96.3) 0.447
Central AP_HR75, % 148/37 6.8 (4.9, 8.6) 7.0 (5.2, 8.9) 7.3 (5.4, 9.2) 7.2 (5.3, 9.1) 0.642
Central AGPH, AS % 148/37 24.8 (20.9, 28.6) 25.4 (21.6, 29.3) 25.9 (22.0, 29.7) 26.5 (22.6, 30.3) 0.217
Central AGPH_HR75, AS % 148/37 16.4 (12.4, 20.3) 17.6 (13.6, 21.5) 18.0 (14.1, 21.9) 18.4 (14.5, 22.4) 0.306
Heart rate, beats/min  148/37 20 (16.2, 24.7) 22 (18.1, 27.6) 23 (18.3, 28.0) 23 (19.0, 29.1) 0.451
Ejection duration, ms 146/37 345.6 (340.5, 350.6) 345.6 (340.5, 350.6) 348.3 (343.2, 353.4) 346.5 (341.4, 351.6) 0.592
1Values are means (for nontransformed variables mean is equal to median) or medians (for the log-transformed variables) with (500) bootstrap 95% CIs
estimated with a joint mixed-effect linear model on BT and AT data, adjusted for subject variability. The treatment effect is statistically significant when
P < 0.05. ABPM, ambulatory blood pressure monitor; Ach, acetylcholine; AGPH, augmentation pressure/pulse height; AGPH_HR75, heart rate–corrected
central augmentation pressure/pulse height; AP_HR75, heart rate–corrected augmented pressure; AS, arterial stiffness; AT, after treatment; BT, before
treatment; CB, control beverage; DBP, diastolic blood pressure; L, the model was built using the log10-transformed variable and the values are
back-transformed in the original scale for the reader’s convenience; LDI, laser Doppler iontophoresis; MP, mean pressure; ms, milliseconds; n, number of
observations; N, number of subjects; PP, pulse pressure; PU, perfusion units; PWA, pulse wave analysis; SBP, systolic blood pressure; SNP, sodium
nitroprusside; WA, whole apple.
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cholesterol according to the European Food Safety Authority
(40). The daily intake of soluble fiber in the apple group in our
study was 3.7 g. Pectin is the major component of soluble fiber
in apples, therefore this amount might not be sufficient alone to
lower TC and a major role of polyphenols, especially PAs, and/or
a synergetic effect between apple polyphenols and pectin/soluble
fiber cannot be excluded (41).
The matrix of a whole food, such as apples, can affect the
release of nutrients, e.g., sugars, fiber, and polyphenols, as well
as their fate and function in the body compared with a simple
sugar beverage (5). Of the aforementioned studies, two have
explored the effects of a clear apple juice on lipid metabolism in
comparison with WAs. Ravn-Haren et al. (15) have shown that
a clear apple juice (total polyphenols, 108 mg/d; total pectin,
0.03 g/d; total sugars, 63 g/d) intake for 4 wk, in 23 healthy
participants, increased LDL cholesterol compared with WAs
(total polyphenols, 239 mg/d; total pectin, 2.87 g/d; total sugars,
51 g/d). On the contrary, Hyson et al. (11) found no differences
in blood lipid concentrations of 25 healthy participants after the
intake of fresh WAs or an unsupplemented apple juice for 6 wk;
however, this study did not include nutrition information about
the tested products. In our study, although there was a tendency
toward a significant increase in insulin after the CB, changes
in glucose and adiponectin were not seen. However, potential
further adverse effects on lipid and glucose metabolism related
to the food matrix and glycemic index of the CB compared with
the WA cannot be excluded.
Endothelial function can serve as an indicator of cardio-
vascular health. We found small but significant improvements
in endothelium-dependent microvascular vasodilation (42) after
the apple intake. To date, only 2 studies to our knowledge
have assessed the long-term effects of apple intake on vascular
function, showing beneficial effects with high-flavonoid apples
(19) but not with dried apples (17). Improvement in vascular
function has been mainly shown with a high daily dose of
flavonoid monomers such as epicatechin (48–180 mg) and/or
quercetin (184–195 mg), either postprandially (19, 24) or after
a 4-wk treatment (19). The lower daily intakes of flavanol
monomers in our study suggest a potential role for the apple
PAs. Longer-term studies with PA-rich foods/beverages such
as chocolate (43) and tea (44) have also reported beneficial
effects on vascular function. Although PA bioavailability is low
comparedwith the readily absorbed flavanol monomers, PAswith
a degree of polymerization >4 reach the colon almost intact
where they are degraded into phenolic acids by gut bacteria
and absorbed into the circulation, where they may contribute to
systemic health-promoting properties (45).
In addition, endothelial dysfunction has been related to a
proinflammatory phenotype. Endothelial adhesion molecules
such as VCAM-1, ICAM-1, E-selectin, and P-selectin are
proinflammatory proteins which play a critical role in the
adhesion of leukocytes to endothelial cells during the early
stages of atherosclerosis (46). Their concentration is low in
normal conditions, but they can increase when the endothelium
is activated by stimuli such as proinflammatory cytokines and
reactive oxygen species (46). In the present study, apple intake
reduced plasma ICAM-1. ICAM-1 and VCAM-1 have been
shown to decrease after a vitamin C–rich apple juice (21), but not
after the intake of a cloudy apple juice (20). Nevertheless, PAs
from other sources such as red wine (47) have also been shown
to decrease ICAM-1 and VCAM-1 in healthy humans.
Circulating BAs have been linked with regulatory functions in
lipid and energy metabolism via binding to nuclear receptors and
acting as signaling molecules (48). In our study, no differences
were observed in blood BA concentrations. However, BA
metabolism is complex and regulated by many parameters, which
are still unclear (49). Interestingly, our exploratory analysis
indicated differential TC and BA profile responses in men and
women after apple consumption, with circulating LCA and
GUDCA predicting the TC response in women. LCA is an
agonist of farnesoid X receptor (FXR), activation of which
reduces BA synthesis in the liver via fibroblast growth factor-19
signaling (50, 51), whereas GUDCA is an antagonist for FXR,
recently shown to improvemetabolic endpoints in humans related
to diabetes (52). Significant sex differences in TC response after
apple intake have been reported previously, with women showing
the largest response (15). Similar sex differences have been
shown to be dependent on BAs and their receptors in animal
studies (53, 54). However, our study was not powered to explore
sex differences; therefore, this warrants closer examination in
specifically designed human intervention studies powered for
comparison between sexes.
Strengths of this study include its adequately powered sample
size, duration, crossover design, the use of a sugar- and energy-
matched control, and the determination of a wide range of
outcomes relative to other similar studies focusing on fresh apples
(5). Another strength is the confirmation of good compliance
using appropriate recognized biomarkers of apple intake in urine
(phloretin metabolites). However, there were some limitations.
The volunteers’ diet was not restricted in terms of polyphenol-
rich products such as fruits, vegetables, and beverages as in
other similar studies (15). However, polyphenols and fiber dietary
intake increased only after the intake of WAs and compliance
to the treatments was confirmed. Another potential limitation
was that volunteers were not blinded to the interventions, a
common limitation when using whole foods (fresh apples).
However, participants were told there may be benefit from either
intervention and researchers in the study were blinded during
analysis. In addition, the use of an apple beverage as a control,
although appropriate to explore the potential beneficial effects of
the polyphenol and fiber components of a whole food such as
apple, does not take into account the effects of the food matrix as
already discussed. Finally, this study was not powered to explore
sex differences; these are only exploratory and need confirmation
in studies adequately powered to explore sex effects.
In conclusion, our findings show clear cause and effect
between inclusion of 2 Renetta Canada apples into normal diets
and improved CVD risk factors, by reducing TC, LDL choles-
terol, and ICAM-1 and increasing microvascular vasodilation, in
healthy subjects with mildly raised serum cholesterol concen-
trations. Dose- and structure-response studies are necessary to
explore the potential mechanisms, which are likely to involve
BA signaling and/or small phenolic acids derived from apple
polyphenols, both linked to gut microbiota metabolism.
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